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A high level of psychological distress is a normal reaction to a
stressful event, e.g. a cancer diagnosis, most commonly soon after
the event (Horowitz, 1993). The most common reactions in cancer
patients are anxiety and depression (Derogatis et al, 1983; Glanz
and Lerman, 1992). The prevalence figures for anxiety and depres-
sion disorders range from 0 to 49% (Spijker et al, 1997, for a
review). Anxiety decreases over time, but there is usually no
significant decrease in depression. Meta-analyses have shown that
the average levels of anxiety and overall psychological distress in
cancer patients during follow-up do not differ significantly from
those of the normal population. However, the levels of depression
are higher (Spijker et al, 1997).
In a preceding study (Nordin and Glimelius, 1997), we found
low average levels of anxiety and depression in a group of newly
diagnosed gastrointestinal cancer patients. However, despite low
average levels, some individuals had high levels of either anxiety
or depression, or both, not only soon after the diagnosis, but also
during follow-up. For those in whom the distress does not decrease
over time, psychological interventions may be necessary, and it is
important to identify these patients as early as possible. The
demonstrated lack of training and skills, in non-specialized clini-
cians and nurses, in detecting psychological distress in cancer
patients (Maguire, 1992) suggests the need for a complementary
method to identify patients who are at risk of psychological
distress, and especially those who are at risk of prolonged distress.
In some studies, prediction of outcome by means of baseline
anxiety and depression measured by the HAD scale has been
attempted, but none of the studies concerned gastrointestinal cancer
patients (Burton et al, 1995; Leigh et al, 1995). Several studies have
also shown that cancer patients may benefit from psychological
interventions (Watson, 1983; Andersen, 1992, Trijsburg et al,
1992). The use of cognitive—behavioural techniques is well estab-
lished for the treatment of both anxiety and depression in cancer
patients (Greer et al, 1992; Fawzy et al, 1993; Watson et al, 1996).
In the study by Greer et al (1992), patients who received adjuvant
psychological therapy reported significant improvements in
various measures of psychological distress, especially anxiety.
Watson et al (1996), however, found no significant changes in
psychological distress before vs after a cognitive—behavioural treat-
ment programme developed for cancer patients. One important
difference between these two studies is that the patients selected for
the Greer et al (1992) study suffered from high levels of psycholog-
ical distress, whereas the patients in the study by Watson et al
(1996) were all self-referred. In studies of psychological interven-
tions with cancer patients recruited consecutively without any
selection, it may be difficult to show any effects of the interven-
tions. Andersen (1992) makes a distinction between psychological
interventions for low, moderate and high morbidity risk patients.
This distinction is important for the evaluation of interventions,
since the rate of spontaneous recovery may vary with the risk of
psychosocial morbidity (Andersen, 1992).
The aim of the present study was to investigate to what extent it
is possible to predict elevated levels of anxiety and depression 6
months after the diagnosis in a group of gastrointestinal cancer
patients. It may not be realistic to provide psychological support to
all patients who want it, or even to all patients with moderate or
high levels of anxiety and depression at diagnosis. However, it is
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elevated levels of anxiety and depression several months after the
diagnosis. The following specific research questions were raised.
(1) To what extent can anxiety and depression 6 months after
diagnosis be predicted on the basis of measures of anxiety,
depression, subjective distress and coping close to the
diagnosis?
(2) Is it possible to identify individual patients with moderate or
high levels of depression and anxiety 3 months (non-cured
patients) or 6 months (potentially cured patients) after the
diagnosis on the basis of the same factors?
PATIENTS AND METHODS
Patients
A consecutive series of newly diagnosed patients from the three
hospitals in the county of Uppsala with gastrointestinal cancers
(colon, rectum, gastric, pancreatic and biliary) were asked to
participate. Patients were excluded who did not speak Swedish,
had a very poor performance (Karnofsky performance status †30)
or were senile or confused.
Data on age, gender, diagnosis and whether or not the patient
was potentially cured (surgically inextirpable primary and/or
metastatic non-resectable disease), obtained close to the diagnosis,
were compiled from the medical records (Table 1).
Study design
Patients who agreed to participate were interviewed as soon as
their physical status permitted, or within 12 weeks from the date of
the diagnostic biopsy or primary surgery (median 3 weeks). The
patients who were considered not to be cured at diagnosis were
interviewed again after 3 months because of their expected short
survival. Both groups were interviewed after 6 months.
Participation and compliance
Of 196 eligible patients, 159 (81%) were interviewed in connec-
tion with the diagnosis. Of those who did not participate, 30 chose
not to do so, three were hard of hearing and four were not aware of
their diagnosis. The non-participants (22 patients with colorectal
cancer, ten with gastric and five with pancreatic/biliary cancer)
were older (mean 78 years, range 51—88) than the participants
(mean 67 years, range 23—89), and there were more women (n =
24) than men (n = 13) in this group. The number of patients inter-
viewed on each different occasion is shown in Table 1. Of the
non-cured patients not interviewed at 3 months, 27 had died, five
were in too poor a condition, one did not want to participate and
two could not be traced. At 6 months, a further 11 patients had
died, one was in too poor a condition and one did not want to
participate. Of the potentially cured patients not interviewed at 6
months, one had died, four were in too poor a condition and four
did not want to participate.
Measures
The interviews were based on structured questionnaires assessing
coping, subjective distress, anxiety and depression.
Coping
The Mental Adjustment to Cancer (MAC) scale consists of 40
items constituting five subscales (coping styles): fighting spirit (16
items), hopeless/helplessness (six items), anxious preoccupation
(nine items), fatalistic (eight items) and avoidance (one item)
(Watson et al, 1988). Except for avoidance, these subscales show
good psychometric properties (Watson et al, 1988; Greer et al,
1989). As suggested by Schwartz et al (1992), the avoidance
subscale was eliminated from the analysis.
Subjective distress
The Impact of Event Scale (IES) assesses current subjective
distress due to a specific life event (Horowitz et al, 1979; Horowitz,
1993), which in the present study is the distress due to the diagnosis
of a cancer disease. It is a 15-item scale that measures intrusion
(range 0—35), characterized by unbidden thoughts and/or images of
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Table 1 Number of patients (potentially cured/non-cured) interviewed at
diagnosis and after 6 months
Diagnosis 6 months
n 82/77 69/31
Colon 41/8 37/4
Rectum 29/10 25/6
Gastric 11/21 6/14
Biliary, pancreatic 0/38 0/17
Male 48/33 41/14
Female 34/44 28/17
Age (mean) 68 (range 23–89) 66 (range 23–89)
Table 2 Mean scores of HAD anxiety and depression at diagnosis and after
6 months
Diagnosis 6 months
Mean s.d. Mean s.d.
All
(n = 151)
Anxiety 4.0 4.2
Depression 4.4 3.9
(n = 98)
Anxiety 3.6 3.6 3.0 2.8 P < 0.05
Depression 3.7 3.3 3.0 2.7 P < 0.05
Table 3 Prediction of HAD anxiety and/or depression 6 months after
diagnosis on the basis of anxiety, depression, subjective distress and coping
close to the diagnosis
R2 b s.e. (b) t
HAD anxiety at 6 months
Anxiety 0.31 0.27 0.10 2.7**
Depression 0.35 0.25 0.10 2.5*
HAD depression at 6 months
Depression 0.31 0.33 0.09 3.67**
Hopeless/helplessness 0.34 0.23 0.10 2.3*
Sum of HAD anxiety and
depression at 6 months
Depression 0.37 0.67 0.15 4.47**
Intrusion 0.41 0.18 0.08 2.25*
*P < 0.05, **P < 0.01the event, and avoidance (range 0—40), characterized by denial of
meanings and consequences of the event. The level of distress is
considered to be low at a score of 0—8, medium at 9—19 and high at
20 or above (Horowitz, 1993). The patient is asked to estimate the
frequency of each item during the last week on a four-point scale
ranging from ￿not at all￿ to ￿often￿.
Anxiety and depression
The HAD scale consists of two subscales, one assessing depres-
sion (seven items) and one anxiety (seven items). Subscale scores
range from 0 (no distress) to 21 (maximum distress) (Zigmond and
Snaith, 1983). Zigmond and Snaith (1983) suggested a score of 7
or less as indicative of a ￿non-case￿, 8—10 as a ￿doubtful case￿ and
a score of 11 or more as a ￿case￿.
Statistical analysis
Stepwise regression analyses were performed to determine how
much of the variance in anxiety and depression at 6 months after
the diagnosis was explained by anxiety, depression, subjective
distress and coping close to the diagnosis. The extent to which it
was possible to identify patients with moderate (doubtful cases) or
high levels (cases) of delayed anxiety and depression was assessed
in terms of sensitivity, specificity and overall predictive value.
Sensitivity expresses the correct proportion of identified cases
(number of true positives/number of true positives plus number of
false negatives) and specificity is the proportion of correctly
identified non-cases (number of true negatives/number of true
negatives plus number of false positives). One-factor ANOVA
(repeated measures) were performed to determine changes over
time and two-tailed (unpaired) t-tests were used for calculating
differences in observed frequencies.
RESULTS
Prediction of anxiety and/or depression 6 months after
diagnosis
Mean HAD scores at diagnosis were 4.0 for anxiety and 4.4 for
depression. Patients who survived and were interviewed after 6
months had lower mean values of HAD depression (mean 3.7) in
connection with the diagnosis than those who did not (mean 5.8,
t = 3.2, P < 0.01). There was no corresponding difference in mean
values of anxiety. There was a significant decrease over time in
both mean HAD anxiety and depression (Table 2).
In a stepwise regression analysis, including the independent vari-
ables (data at diagnosis) HAD anxiety and depression, the MAC
scale (fighting spirit, hopeless/helplessness, anxious preoccupation
and fatalism) and the IES scale (intrusion and avoidance), HAD
anxiety (31%) and depression (4%) accounted for a total of 35% of
the variance in anxiety that was found 6 months later. For HAD
depression 6 months after the diagnosis, 31% of the variance was
explained by depression close to the diagnosis and 3% by hope-
less/helplessness. When the 6-month scores for anxiety and depres-
sion were summarized, 37% of the variance was explained by
depression and 4% by intrusion at diagnosis (Table 3). In an effort to
avoid the multicollinearity problem, i.e. when variables are highly
correlated, some of the coping scales were excluded from the
analysis. This did not affect the pattern of results (data not shown).
Inclusion of age, sex or state of illness (potentially cured/non-cured
at diagnosis) in the multivariate analyses did not change the results,
and no additional explanation was provided (data not shown).
Prospective identification of anxiety and/or depression
‘doubtful cases’ or ‘cases’
Of the patients who were alive 3 (non-cured patients) or 6 (poten-
tially cured patients) months after the diagnosis, 24 (21%) scored as
￿doubtful cases￿ or ￿cases￿ for HAD anxiety and/or depression close
to the diagnosis. Twelve of these patients still scored as ￿doubtful
cases￿ or ￿cases￿ 3 or 6 months later. Close to the diagnosis, 89
(78%) patients scored as ￿non-cases￿ and 87 (98%) of those did so 3
or 6 months later (Table 4). Using ￿doubtful cases￿ or ￿cases￿ for
HAD anxiety or depression close to the diagnosis for the selection
of patients who may need psychological intervention, i.e. score as
￿doubtful cases￿ or ￿cases￿ after 3 or 6 months, respectively, gives a
sensitivity of 50% and a specificity of 98% (Model 1, Table 4).
An alternative model for the identification of patients at diagnosis
for whom psychological intervention may be necessary is to employ
￿doubtful cases￿ or ￿cases￿ for HAD anxiety or depression together
with scores above the cut-off level of 9 (medium to high subjective
distress) for IES intrusion. This model (Model 2, Table 4) reaches a
higher sensitivity (75%) while retaining a very high specificity
(98%) compared with the use of the HAD scales alone (Table 4).
DISCUSSION
Patient anxiety and depression close to the diagnosis were shown
to explain approximately 35% of the variance in anxiety and
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Table 4 Number of patients who scored as ‘doubtful cases’ or ‘cases’ for HAD anxiety and depression after 3 or 6 months
related to how they scored at diagnosis using the HAD scale alone (Model 1) or the HAD scale supplemented by IES intrusion
(Model 2)
HAD ‘doubtful cases’ or
Model Scoring at diagnosis ‘cases’ after 3 or 6 monthsa
Yes No
1. HAD ‘doubtful cases’ Yes 24 12 12
or ‘cases’ No 89 2 87
Yes No
2. HAD ‘doubtful cases’ Yes 16 12 4
or ‘cases’ and No 97 2 95
above cut-off for IES
intrusion
aData for non-cured patients scored at 3 months and for potentially cured patients at 6 months.depression that was found 6 months later. Thus, levels of anxiety
and depression at diagnosis are predictive of a similar status 6
months later. The addition of data on coping strategies and subjec-
tive distress does very little to improve that prediction.
Multiple regression analyses for prediction yield information only
about the proportion of variance explained by various independent
variables. This kind of knowledge is not easily applied in everyday
clinical decision-making about individual patients. For example,
these analyses do not allow identification of individual patients at
risk of delayed anxiety and depression. We therefore sought an alter-
native procedure with better applicability to clinical situations,
namely, to identify prospectively patients scoring as ￿doubtful cases￿
or ￿cases￿. Using ￿doubtful cases￿ or ￿cases￿ for HAD anxiety and/or
depression to select patients at risk of prolonged psychological
distress demonstrated that 50% of those selected may not be in great
need of psychological intervention. Thus, half of patients will be
offered an intervention unnecessarily because they spontaneously, or
with the help of the regular care system, improve to such an extent
that they no longer belong to the categories ￿doubtful cases￿ or
￿cases￿. In the same way, inclusion of IES intrusion data will lead to
unnecessary interventions for 25% of the patients. Practically no
patients (2%) will be missed in either model.
Identification at diagnosis of patients at risk for elevated
delayed levels of anxiety and depression should facilitate early
psychological intervention for this group. The HAD scale has been
shown to be a sensitive tool for the screening of psychiatric disor-
ders among cancer patients (Razavi et al, 1990). Optimally, all
newly diagnosed cancer patients who want professional psycho-
logical support should be offered this. However, an important
consideration is then the cost of such support, in terms of both
professional time and resources. Such considerations are particu-
larly important as not all patients suffer from high levels of
psychological distress close to the diagnosis. In addition, distress
seems to decrease for most patients independently of psycho-
logical support from health care staff (Glanz and Lerman, 1992),
as is also evident from the present data. If resources are limited, it
may be economically impossible to intervene for all patients who
express high levels of distress after diagnosis.
All adjuvant protocols, whether pharmacological or psycho-
logical, used to decrease the proportion from suffering a negative
event imply overtreatment of a significant proportion. Ideally, a
higher sensitivity than reached here would have been desirable.
However, if 25% or even 50% of the patients were to receive
￿unnecessary￿ psychological interventions, this would not result in
high economic costs. The number of gastrointestinal cancer
patients in need of psychological interventions (in this study
defined as having elevated levels of HAD anxiety or depression) is
rather limited. Also, several patients in adjuvant psychological
protocols, mostly those not truly in need of the treatment, volun-
tarily drop out after one or two sessions (Hellbom et al, 1998).
Several factors have been suggested to influence the levels of
psychological morbidity in cancer patients (Harrison and Maguire,
1994). Some of these are demographic factors (e.g. age, gender
and marital status), pre-morbid psychological factors (e.g. self-
esteem and past psychiatric history) and environmental factors
(e.g. social support). These factors are consequently important for
the physician to address, but as a complement, an easily completed
questionnaire may be of advantage by helping the physician to
detect patients at high risk for prolonged psychological distress.
The minimal additional value of the MAC scale as a predictor of
later anxiety and depression may be explained by difficulties
separating coping, measured by the MAC scale, from the
outcomes of the coping efforts. In a preceding study (Nordin,
1997), we also found it difficult to separate coping as measured by
the MAC scale, especially hopeless/helplessness and anxious
preoccupation, from the outcome of the coping efforts, in this case
HAD anxiety and depression. Thus, these scales may largely
measure the same phenomena.
The use of the HAD scale, in combination with the IES intru-
sion subscale, to detect patients who are at risk for delayed anxiety
and depression has not been tested before. Therefore, this study
should be considered as exploratory, particularly as the number of
patients scoring as ￿doubtful cases￿ or ￿cases￿ 3 or 6 months after
diagnosis is small. If the results can be confirmed on larger patient
series, this combination of scales could be practically useful.
In conclusion, levels of HAD anxiety and depression at diag-
nosis predict a similar status 6 months later. The addition of coping
does very little to improve that prediction. The results also suggest
that the HAD scale in combination with the IES intrusion subscale
may be used as a tool for detecting patients at risk for prolonged
psychological distress. Patients scoring as ￿doubtful cases￿ or
￿cases￿ for HAD anxiety or depression and above a cut-off of 9 in
the intrusion subscale should be offered early psychological inter-
vention. It should be noted that the scales are easy to handle for
both the physician and the patients.
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